Non-small Cell Lung Cancer With Proto-Oncogene B-Raf V600E Presenting a Distinctive Clinical Course: A Case Report

Cases of proto-oncogene B-Raf (BRAF) V600E mutation are rare, accounting for 1%-4% of non-small cell lung cancers (NSCLCs), and its clinical features remain unclear. Here, we report a case of BRAF mutation-positive lung adenocarcinoma with an atypical clinical course and long-term survival. The pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Sasada, Aosa, Yuba, Tatsuya, Shiotsu, Shinsuke, Tsuji, Taisuke, Hiraoka, Noriya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9001854/
https://www.ncbi.nlm.nih.gov/pubmed/35464513
http://dx.doi.org/10.7759/cureus.23055

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9001854/
https://www.ncbi.nlm.nih.gov/pubmed/35464513
http://dx.doi.org/10.7759/cureus.23055

Ejemplares similares